Fig. 3: The BH4 domain of Bcl-2 inhibits IP3R-mediated Ca2+ release in Bcl-2 KO PACs. | Cell Death Discovery

Fig. 3: The BH4 domain of Bcl-2 inhibits IP3R-mediated Ca2+ release in Bcl-2 KO PACs.

From: BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis

Fig. 3

a–c Typical traces of the Fluo-4AM single-cell Ca2+ measurements performed in Bcl-2 KO mouse PACs. At the start of each experiment cells were perfused with NaHEPES containing DMSO (vehicle, Fig.Ā 3a). After establishing the baseline (200 s), ACh (200 nM) was added and IP3R-mediated Ca2+ oscillations were measured for 5 min. Then, 50 µM of either the control peptide (a), the BH4 domain of Bcl-2 (b) or the BH4 domain of Bcl-XL (c) were added for 10 min, in the continuous presence of 200 nM ACh. d Quantification of the experiments: The area under the curve per second (AUC/sec) of the ACh-induced Ca2+ release after peptide addition (10 min recording) was compared to the AUC/sec before peptide addition (5 min recording). Each data point represents the measurement of an individual cell. The average values ± SEM are shown (P-value <0.0001). At least three independent experiments were performed per condition (N ≄ 3). For each conditionĀ at least 35 cells were recorded

Back to article page